GLAUKOS Corp 4

Glaukos CFO Alex R. Thurman exercised 20,000 stock options at $33.81 and sold 20,000 Glaukos (GKOS) common shares around $180.13 on August 7, 2026 under a Rule 10b5-1 plan.

On August 7, 2026, Glaukos Corporation SVP & Chief Financial Officer Alex R. Thurman exercised 20,000 stock options at an exercise price of $33.81 per share, acquiring 20,000 shares of common stock, and immediately sold 20,000 shares of common stock at a weighted average price of $180.13 per share under a Rule 10b5-1 trading plan adopted on December 15, 2025. The option exercise generated shares valued at roughly $676,200, while the corresponding sale generated proceeds of about $3.60 million, effectively realizing a spread of approximately $2.93 million before taxes and transaction costs. Following these transactions, Thurman’s direct ownership stood at 43,906 shares of common stock (including 5,230 unvested RSUs and 225 ESPP shares), with an estimated market value of about $7.99 million based on a recent trading price of $182 per share, indicating the transactions were primarily a liquidity and diversification event rather than a reduction of core equity exposure.

Filing Facts

CIK

1192448

Ticker

GKOS

Form

4

Source Type

fda

Accession

0001920061-26-000018

Alert Tier

6